AIDS

1. HAGE K, Carson J, Hosseini-Hooshyar S, Sacks-Davis R, et al
   Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studies.
   AIDS. 2025 Nov 17. doi: 10.1097/QAD.0000000000004408.
   

   >> Share

   
   
2. BABU AM, Janzen D, Evans CD, Spence C, et al
   Antiretroviral utilization and adherence before versus after expansion of a provincial drug insurance policy.
   AIDS. 2025 Nov 17. doi: 10.1097/QAD.0000000000004409.
   

   >> Share

   
   
3. VELOSO M, Ribeiro M, Cabanas J, Goncalves F, et al
   Emerging patterns in HIV integrase resistance.
   AIDS. 2025;39:2324-2327.
   

   >> Share

   
   
4. DE ARMAS LR, Tuyishime M, Justement JS, Jha S, et al
   Resistance to broadly neutralizing antibodies in perinatally infected infants from a Clade C HIV cohort in Mozambique.
   AIDS. 2025;39:2321-2324.
   

   >> Share

   
   
5. NGHIEM VTH, Braithwaite RS
   COVID-19 as a natural experiment intervention to reduce new HIV infections among Australian MSM.
   AIDS. 2025;39:2319-2320.
   

   >> Share

   
   
6. JEENA L, Kahari C, Ward KA, Gregson CL, et al
   The effects of HIV on bone and muscle health through the lifespan in populations living in Africa.
   AIDS. 2025;39:2161-2175.
   

   >> Share

   
   
7. DHANJAL A, Shaw JG, Cole J, Green LR, et al
   Intersecting infections: the enhancing effect of Neisseria gonorrhoeae pathogenesis on HIV-1.
   AIDS. 2025;39:2151-2160.
   

   >> Share

   
   
8. BRUMMEL SS, Swanson S, Caniglia E, Lockman S, et al
   A lesson in embracing uncertainty in early safety signals from the Tsepamo study.
   AIDS. 2025;39:2266-2273.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

9. BACHELARD A, Julia Z, Damond F, Barral T, et al
   Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1-Infected Pregnant Women: Real-Life Use.
   AIDS Res Hum Retroviruses. 2025 Nov 17. doi: 10.1177/08892229251398861.
   

   >> Share

   
   

   
   BMC Cancer

10. MANSFIELD ME, Volpi CR, John C, Adebiyi R, et al
    Facilitator and barrier perspectives on learning and implementing high-resolution anoscopy in Abuja, Nigeria: a qualitative study.
    BMC Cancer. 2025;25:1766.
    

    >> Share

    
    

    
    Clin Infect Dis

11. ZUGER A
    Home testing for contagious illness: Historical context and modern caveats.
    Clin Infect Dis. 2025 Nov 14:ciaf623. doi: 10.1093.
    

    >> Share

    
    
12. MARTINEZ-SANZ J, Garcia-Ruiz de Morales AG, Macias J, Rivero A, et al
    Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023.
    Clin Infect Dis. 2025 Nov 14:ciaf622. doi: 10.1093.
    

    >> Share

    
    
13. MURRILL MT, Velasquez GE, Szumowski JD, Phillips A, et al
    Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures.
    Clin Infect Dis. 2025 Nov 19:ciaf628. doi: 10.1093.
    

    >> Share

    
    
14. VAN SANTEN DK, Chalouni M, Berenguer J, Jarrin I, et al
    Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIV.
    Clin Infect Dis. 2025 Nov 19:ciaf635. doi: 10.1093.
    

    >> Share

    
    
15. OLCOTT F, Oddie PD, Barlow MJ, Mamarelis A, et al
    Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice.
    Clin Infect Dis. 2025 Nov 19:ciaf634. doi: 10.1093.
    

    >> Share

    
    
16. KWAGHE VG, Erameh C, Vongdip NG, Edeawe OI, et al
    Fulminant Yersinia Pestis Infection in a Known HIV-Positive Patient: A Case Report of Identification in Nigeria 2024.
    Clin Infect Dis. 2025;81.
    

    >> Share

    
    

    
    HIV Med

17. SUAREZ-GARCIA I, Alejos B, Moreno C, Izquierdo R, et al
    Diagnosis of HIV infection during pregnancy: Trends from a national cohort in Spain.
    HIV Med. 2025 Nov 21. doi: 10.1111/hiv.70148.
    

    >> Share

    
    
18. MOTLOKWA PK, Ruffieux Y, Chinogurei C, Haas AD, et al
    Survival among medically insured and treated head and neck cancer patients with and without HIV in South Africa.
    HIV Med. 2025 Nov 19. doi: 10.1111/hiv.70143.
    

    >> Share

    
    
19. DYER CEF, Jin F, Roberts JM, Poynten IM, et al
    Anal cancer screening in men who have sex with men living with HIV: The pilot of anal screening study (PASS).
    HIV Med. 2025 Nov 18. doi: 10.1111/hiv.70151.
    

    >> Share

    
    
20. ST CLAIR-SULLIVAN N, Bristowe K, Bremner S, Maddocks M, et al
    Comprehensive geriatric assessment for people living with HIV and frailty: A mixed-methods feasibility randomized controlled trial.
    HIV Med. 2025 Nov 21. doi: 10.1111/hiv.70149.
    

    >> Share

    
    
21. ADEDOKUN KA, Adebisi TA, Bello A, Fayemo HT, et al
    HIV/AIDS in transition: Global disparities, Africa's uneven progress and struggles, and the emerging threat of funding cuts (global burden of disease study, 1990-2021).
    HIV Med. 2025 Nov 21. doi: 10.1111/hiv.70144.
    

    >> Share

    
    

    
    Int J Cancer

22. GRABAR S, Lakrout P, Potard V, Belot A, et al
    Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV.
    Int J Cancer. 2025 Nov 20. doi: 10.1002/ijc.70253.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

23. GRAYBILL LA, Huffstetler HE, Mtande TK, Krysiak R, et al
    Identifying pregnant women at high risk of HIV acquisition: An external validation assessment of an HIV risk assessment tool for pregnant women.
    J Acquir Immune Defic Syndr. 2025 Nov 17. doi: 10.1097/QAI.0000000000003798.
    

    >> Share

    
    
24. ALVAREZ JA, Teeny S, Yang CA, Mehta CC, et al
    Altered lipid and neurotransmitter metabolism as potential mechanisms of weight gain in women with HIV initiating INSTIs in a pilot study.
    J Acquir Immune Defic Syndr. 2025 Nov 18. doi: 10.1097/QAI.0000000000003799.
    

    >> Share

    
    
25. BASSETT IV, Yan J, Govere S, Johnson LS, et al
    PrEP and contraceptive persistence among young women receiving sexual and reproductive health services through hair salons in South Africa.
    J Acquir Immune Defic Syndr. 2025 Nov 18. doi: 10.1097/QAI.0000000000003800.
    

    >> Share

    
    
26. ONOYA D, Shumba K, Mudara C, Nattey C, et al
    Timing of ART initiation with treatment policy changes in South Africa: a cohort study.
    J Acquir Immune Defic Syndr. 2025 Nov 18. doi: 10.1097/QAI.0000000000003797.
    

    >> Share

    
    
27. NALUGGA EA, Musaazi J, Manabe YC, Kalema N, et al
    Adverse drug reactions related to isoniazid preventive therapy among persons living with HIV on dolutegravir-based regimens in Uganda between July 2019 and March 2020.
    J Acquir Immune Defic Syndr. 2025 Nov 19. doi: 10.1097/QAI.0000000000003802.
    

    >> Share

    
    
28. SERGHIDES L, Lee J, Jacobson DL, Geffner ME, et al
    Is gestational exposure to HIV and protease inhibitors associated with timing of pubertal onset?
    J Acquir Immune Defic Syndr. 2025 Nov 19. doi: 10.1097/QAI.0000000000003801.
    

    >> Share

    
    

    
    J Clin Immunol

29. STENLANDER C, Lindahl H, Wahren-Borgstrom E, Geier CB, et al
    Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter Study.
    J Clin Immunol. 2025;45:161.
    

    >> Share

    
    

    
    J Infect Dis

30. ZHANG J, Wang Y, Chen L, Feng P, et al
    Efficacy and Safety of Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Infection Among People Living With HIV.
    J Infect Dis. 2025;232.
    

    >> Share

    
    
31. CHAN P, Sacdalan C, Pinyakorn S, Kroon E, et al
    Neuroaxonal Injury in Acute HIV Infection and Following Immediate Antiretroviral Therapy.
    J Infect Dis. 2025 Nov 19:jiaf583. doi: 10.1093.
    

    >> Share

    
    
32. WEISER J
    With All Good Intentions: How CDC Decisions Harmed Science and People.
    J Infect Dis. 2025 Nov 17:jiaf584. doi: 10.1093.
    

    >> Share

    
    
33. GIANELLA S, Taylor J, Shelton B, MacLean F, et al
    In Response to Schmitt et al: Data Do Not Support Exclusionary Policies.
    J Infect Dis. 2025 Nov 14:jiaf580. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

34. FAZLI P, Bakhtiari S, Jalilian FA, Teimoori A, et al
    Clinical and Immunological Impact of Occult Hepatitis B Virus Infection Among HIV-Infected Patients With and Without HCV Co-Infection in Iran: A Cross-Sectional Analysis.
    J Med Virol. 2025;97:e70715.
    

    >> Share

    
    
35. ADACHI E, Okuno S, Kanno Y, Koga M, et al
    Contemporary Antiretroviral Therapy Regimens in People With HIV Who Initiated Treatment in the Pre-Antiretroviral Therapy Era.
    J Med Virol. 2025;97:e70708.
    

    >> Share

    
    

    
    J Virol

36. ZUROWSKA K, Dzhivhuho G, Grabski D, Rekosh D, et al
    Characterization of HERV-K (HML-2) Rec proteins encoded in the human genome and their post-transcriptional function.
    J Virol. 2025 Nov 18:e0151525. doi: 10.1128/jvi.01515.
    

    >> Share

    
    

    
    JAMA

37. MAUERMANN ML, Staff NP
    Peripheral Neuropathy: A Review.
    JAMA. 2025 Nov 17. doi: 10.1001/jama.2025.19400.
    

    >> Share

    
    

    
    Lancet Infect Dis

38. SAMARASEKERA U
    Deniz Gokengin-responding to HIV/AIDS in Turkiye.
    Lancet Infect Dis. 2025;25:1278.
    

    >> Share

    
    
39. KIRBY T
    Seema Sahay-linking behavioural science and HIV research.
    Lancet Infect Dis. 2025;25:1277.
    

    >> Share

    
    

    
    N Engl J Med

40. SHUTER J, Goel S, Himelhoch SS
    Integration of Tobacco-Cessation Interventions into Tuberculosis and HIV Care.
    N Engl J Med. 2025;393:1969-1972.
    

    >> Share

    
    

    
    Nat Rev Immunol

41. MASOPUST D, Awasthi A, Bosselut R, Brooks DG, et al
    Guidelines for T cell nomenclature.
    Nat Rev Immunol. 2025 Nov 18. doi: 10.1038/s41577-025-01238.
    

    >> Share

    
    

    
    Pediatrics

42. REED JL, Gutman CK
    Closing the HIV Screening Gap in Teens.
    Pediatrics. 2025 Nov 19:e2025073382. doi: 10.1542/peds.2025-073382.
    

    >> Share

    
    
43. BOOLCHANDANI H, Gooding H, Hill S, Jergel A, et al
    Human Immunodeficiency Virus Testing Practices in United States Pediatric Emergency Departments.
    Pediatrics. 2025 Nov 19:e2025072108. doi: 10.1542/peds.2025-072108.
    

    >> Share

    
    

    
    PLoS Comput Biol

44. PARKER NT, Hong V, Davis GS, Pomichowski M, et al
    Clinical progression parameters associated with SARS-CoV-2, influenza, and respiratory syncytial virus infections in a large US integrated healthcare population.
    PLoS Comput Biol. 2025;21:e1013723.
    

    >> Share

    
    

    
    PLoS Med

45. OLBRICH L, Larsson L, Dunbar R, Dodd PJ, et al
    Diagnostic accuracy of the WHO tuberculosis treatment decision algorithms for children with presumptive tuberculosis: An individual participant data meta-analysis.
    PLoS Med. 2025;22:e1004610.
    

    >> Share

    
    

    
    PLoS One

46. SPERLE I, Lunchenkov N, Stepanovich-Falke A, Nurmatov ZS, et al
    Barriers and facilitators to HIV and viral hepatitis testing in primary healthcare settings in the Kyrgyz Republic: A mixed-methods study using the COM-B Framework.
    PLoS One. 2025;20:e0336257.
    

    >> Share

    
    
47. KIP EC, Hosseinipour MC, Kulisewa K, Pence BW, et al
    Cultural adaptation of a psychosocial screening tool for adolescents living with HIV/AIDS attending antiretroviral therapy program in Malawi.
    PLoS One. 2025;20:e0318738.
    

    >> Share

    
    
48. VAN GRIENSVEN F, Mock PA, Benjarattanaporn P, Premsri N, et al
    Correction: Estimating recent HIV incidence among young men who have sex with men: Reinvigorating, validating and implementing Osmond's algorithm for behavioral imputation.
    PLoS One. 2025;20:e0337128.
    

    >> Share

    
    
49. KAAPU KG, Rukasha I
    Trends and treatment outcomes of drug resistant tuberculosis in Limpopo Province, South Africa (2011-2019): A Retrospective Study.
    PLoS One. 2025;20:e0335600.
    

    >> Share

    
    
50. CIANELLI R, De Santis JP, Iriarte E, De Oliveira GC, et al
    SEPA+PrEP-BW intervention: A feasible and acceptable HIV prevention intervention for Black women.
    PLoS One. 2025;20:e0336435.
    

    >> Share

    
    
51. KHUMALO N, Mankahla A, Korsman S, Gumedze F, et al
    Scalp haircuts, keloids and blood-borne virus transmission risk in South Africa-The SHAKA study.
    PLoS One. 2025;20:e0336213.
    

    >> Share

    
    
52. KINAI E, Ishikura M, Miyashita R, Yamaguchi T, et al
    Serology change-based clinical interpretation of indeterminate serostatus post-hepatitis B virus infection in people living with HIV.
    PLoS One. 2025;20:e0336924.
    

    >> Share

    
    
53. KUMAH E, Boakye DS, Agyei E, Boateng R, et al
    Global HIV prevention, treatment, and care interventions and strategies for key populations: Protocol for a scoping review.
    PLoS One. 2025;20:e0337075.
    

    >> Share

    
    
54. KILIMA S, Hirasen K, Mubyazi G, Moolla A, et al
    Implications of pre-diagnosis costs incurred by patients and their families for tuberculosis-related health-seeking behaviors in Mbeya and Songwe regions, Tanzania.
    PLoS One. 2025;20:e0336270.
    

    >> Share

    
    
55. IBRAHIM N, Jones S, Rich K, Alvarez L, et al
    Evaluation of a "one-stop shop" for integrated harm reduction and primary care for people who inject drugs.
    PLoS One. 2025;20:e0337528.
    

    >> Share

    
    

    
    PLoS Pathog

56. ZHANG Y, Klein K, Ratcliff A, Galappaththi SL, et al
    Correction: Transmitted/founder (T/F) HIV-1 derived from sexual contact exhibits greater transmission fitness in human cervical tissue than T/F HIV-1 from blood-to-blood contact: Unique glycan profiles on T/F envelopes associated with transmission phe
    PLoS Pathog. 2025;21:e1013697.
    

    >> Share

    
    

    
    Vaccine

57. RANA MM, Haydel B, Carrara G, Gleason C, et al
    Humoral SARS-CoV-2 vaccine responses are durable in solid organ transplant recipients with and without HIV.
    Vaccine. 2025;69:127969.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share